INKT

8.0206.85%
TC

Terese C. Hammond

Head of Inflammatory & Pulmonary Diseases

Dr. Terese C. Hammond, MD, serves as Head of Inflammatory & Pulmonary Diseases at MiNK Therapeutics, Inc. since September 18, 2025. She served as Medical Director at Boston University Medical Group Sleep Center of Sleep HealthCenters, LLC. Dr. Hammond serves as Assistant Professor of Medicine from Boston University; Sleep Specialist from VA Boston Healthcare System and Board Certified in Pulmonary from Critical Care and Internal Medicine. Dr. Hammond is a nationally recognized leader in pulmonary and critical care medicine with extensive experience advancing registration-stage programs in severe pulmonary and inflammatory diseases. She has served as principal investigator on multiple pivotal studies advancing innovations from Gilead, Regeneron, Roche, Novartis and MiNK and is lead author of MiNKs landmark Nature Communications publication on MiNKs iNKT cell therapy (agenT-797) in acute respiratory distress syndrome (ARDS). Her clinical work has demonstrated meaningful survival benefit and reduced infectious complications in severe acute lung injury and life-threatening hypoxemic pneumonia seminal findings that not only validate the potential of iNKT therapies but also set the foundation for pivotal trials and future registration. Dr. Terese Hammond is a nationally recognized expert in pulmonary and critical care medicine with more than two decades of leadership at top cancer and academic centers. She currently serves as Program Director of Pulmonary & Critical Care at Kaweah Health Medical Center and previously directed intensive care services at Providence St. Johns Health Center, a premier oncology hospital. She has also held senior faculty appointments at UCLA and USC, where she led fellowship programs in pulmonary and critical care medicine. Dr. Hammond trained at Boston University/Boston Medical Center and is quadruple board-certified in Pulmonary Medicine, Critical Care, Neurocritical Care and Sleep Medicine. She also holds a Cancer Immunotherapy Certificate from the Society for Immunotherapy of Cancer. Her research has been published in leading journals including The New England Journal of Medicine, Science Translational Medicine and Clinical Infectious Diseases.

Positions